ATE62481T1 - Leukotrienantagonisten. - Google Patents
Leukotrienantagonisten.Info
- Publication number
- ATE62481T1 ATE62481T1 AT86304665T AT86304665T ATE62481T1 AT E62481 T1 ATE62481 T1 AT E62481T1 AT 86304665 T AT86304665 T AT 86304665T AT 86304665 T AT86304665 T AT 86304665T AT E62481 T1 ATE62481 T1 AT E62481T1
- Authority
- AT
- Austria
- Prior art keywords
- antagonists
- leukotrian
- agents
- compounds
- leukotrienes
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract 1
- 230000036783 anaphylactic response Effects 0.000 abstract 1
- 208000003455 anaphylaxis Diseases 0.000 abstract 1
- -1 anti-allergic Substances 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000002682 anti-psoriatic effect Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000001120 cytoprotective effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000002617 leukotrienes Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74620385A | 1985-06-18 | 1985-06-18 | |
| EP86304665A EP0206741B1 (de) | 1985-06-18 | 1986-06-17 | Leukotrienantagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE62481T1 true ATE62481T1 (de) | 1991-04-15 |
Family
ID=24999872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86304665T ATE62481T1 (de) | 1985-06-18 | 1986-06-17 | Leukotrienantagonisten. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0206741B1 (de) |
| JP (1) | JPS6259239A (de) |
| AT (1) | ATE62481T1 (de) |
| CA (1) | CA1309557C (de) |
| DE (1) | DE3678622D1 (de) |
| DK (1) | DK282886A (de) |
| ES (1) | ES8707918A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5135940A (en) * | 1982-09-23 | 1992-08-04 | Merck Frosst Canada, Inc. | Leukotriene antagonists |
| PT85110A (en) * | 1986-06-23 | 1987-07-01 | Merck Frosst Canada Inc | Process for preparing benzenealkanoic acid derivatives useful as leukotriene antagonists |
| US4906658A (en) * | 1987-04-21 | 1990-03-06 | Merck Frosst Canada, Inc. | Fluoro-sulfones |
| US5149717A (en) * | 1988-03-29 | 1992-09-22 | Ciba-Geigy Corporation | Alkanophenones useful for treating allergies |
| EP0419410A3 (en) * | 1989-09-19 | 1991-08-14 | Ciba-Geigy Ag | Alkanophenones |
| KR101942752B1 (ko) * | 2012-11-05 | 2019-01-28 | 주식회사 엘지화학 | Ｇｐｒ120 효능제로서의 티오아릴 유도체 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3630200A (en) | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4325961A (en) | 1977-06-01 | 1982-04-20 | Merck & Co., Inc. | Fluorinated amino acids |
| PT68303A (en) | 1977-07-26 | 1978-08-01 | Merck & Co Inc | Process for the preparation of dibenzo/b,f/thiepin |
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| PH16099A (en) | 1979-03-06 | 1983-06-24 | Yamanouchi Pharma Co Ltd | Guanidinothiazole compounds,process for preparing them and medical composition containing them |
| JPS6056143B2 (ja) | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | アミジン誘導体ならびにその製造法 |
| GB2058785B (en) | 1979-09-05 | 1983-05-25 | Glaxo Group Ltd | Phenol derivatives |
| US4237160A (en) | 1979-11-27 | 1980-12-02 | Merck Sharp & Dohme (I.A.) Corp. | 3-Hydroxymethyldibenzo[b,f]thiepins as prostaglandin antagonists |
| DE3175201D1 (en) | 1980-04-30 | 1986-10-02 | Merck & Co Inc | Aminothiadiazoles as gastric secretion inhibitors |
| US4394508A (en) | 1980-06-07 | 1983-07-19 | Bristol-Myers Company | Chemical compounds |
| EP0056172B1 (de) | 1981-01-09 | 1985-04-03 | FISONS plc | Phenoxy- und Thiophenoxyverbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
| GB2094301B (en) | 1981-03-03 | 1985-02-06 | Lilly Industries Ltd | Improvements in or relating to organic compounds |
| DE3265715D1 (en) | 1981-03-24 | 1985-10-03 | Fisons Plc | Anti srs-a carboxylic acid derivatives, processes for their production and pharmaceutical formulations containing them |
| US4513005A (en) | 1981-06-18 | 1985-04-23 | Lilly Industries Limited | SRS-A antagonists |
| NZ205559A (en) | 1982-09-23 | 1987-08-31 | Merck Frosst Canada Inc | Leukotriene antagonists, pharmaceutical compositions, and intermediates |
| EP0106565B1 (de) | 1982-09-30 | 1986-09-10 | Merck Frosst Canada Inc. | Leukotrienantagonisten, deren Herstellung und diese enthaltende Zusammensetzungen |
| ES526528A0 (es) * | 1982-10-21 | 1985-05-16 | Lilly Industries Ltd | Un procedimiento para la preparacion de derivados de difenilalquilenicos. |
| NZ206795A (en) | 1983-01-21 | 1987-08-31 | Merck Frosst Canada Inc | Phenothiazines, analogues and pharmaceutical compositions |
| EP0136893B1 (de) | 1983-10-05 | 1989-08-16 | Merck Frosst Canada Inc. | Benzo(a)Phenothiazine und Hydro-Derivate und sie enthaltende pharmazeutische Zusammensetzungen |
| DE3484745D1 (de) | 1983-10-05 | 1991-08-01 | Merck Frosst Canada Inc | Inhibitoren fuer die leukotrien-biosynthese. |
| ES8602588A1 (es) | 1983-10-27 | 1985-12-01 | Merck Frosst Canada Inc | Un procedimiento para la preparacion de nuevos antagonistas de los leucotrienos. |
| ES8602818A1 (es) | 1983-10-31 | 1985-12-01 | Merck Frosst Canada Inc | Una composicion farmaceutica |
| CA1243322A (en) * | 1984-01-23 | 1988-10-18 | Joshua Rokach | Antagonists of slow reacting substances of anaphylaxis |
-
1986
- 1986-06-13 CA CA000511571A patent/CA1309557C/en not_active Expired - Lifetime
- 1986-06-17 AT AT86304665T patent/ATE62481T1/de active
- 1986-06-17 EP EP86304665A patent/EP0206741B1/de not_active Expired - Lifetime
- 1986-06-17 ES ES556126A patent/ES8707918A1/es not_active Expired
- 1986-06-17 DE DE8686304665T patent/DE3678622D1/de not_active Expired - Lifetime
- 1986-06-17 DK DK282886A patent/DK282886A/da not_active Application Discontinuation
- 1986-06-18 JP JP61142459A patent/JPS6259239A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES8707918A1 (es) | 1987-09-01 |
| EP0206741A2 (de) | 1986-12-30 |
| DK282886D0 (da) | 1986-06-17 |
| DE3678622D1 (de) | 1991-05-16 |
| ES556126A0 (es) | 1987-09-01 |
| CA1309557C (en) | 1992-10-27 |
| EP0206741A3 (en) | 1987-12-23 |
| JPS6259239A (ja) | 1987-03-14 |
| EP0206741B1 (de) | 1991-04-10 |
| DK282886A (da) | 1987-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI902555A0 (fi) | Diarylstyrylkinolindisyror. | |
| SE8505112D0 (sv) | Novel pharmacological compounds | |
| DE69814375D1 (de) | Fungizide trifluoromethylalkylamino-triazolopyrimidine-derivate | |
| FI861683A0 (fi) | N-indolyletyl-sulfonsyra-amider, foerfarande foer deras framstaellning och deras anvaendning. | |
| IL84359A0 (en) | Substituted cephalosporin sulfones,their preparation and pharmaceutical compositions containing them | |
| NZ222015A (en) | 7-(meta-substituted phenylglycine)-1-carba-1-dethiacephalsporins and pharmaceutical compositions | |
| ES8504130A1 (es) | Un metodo para preparar derivados de 4-hidroxi-2-quinolona | |
| DK0404440T3 (da) | Substituerede sulfonamider og beslægtede forbindelser til behandling af astma, arthritis og beslægtede sygdomme | |
| IT1224405B (it) | Composti attivi sul sistema cardiovascolare | |
| DE3678622D1 (de) | Leukotrienantagonisten. | |
| DE3587112D1 (de) | 2-quaternaer-pyridinalkylthio- oder -pyridinalkenylthiosubstituierte carbapeneme, diese enthaltende zusammensetzungen und ihre zusammenstellungen mit dhp-inhibitoren. | |
| DK521685A (da) | Spergualin-derivater og anvendelse deraf til fremstilling af laegemidler med immunosuppressiv virkning | |
| FR2422638A1 (fr) | Nouveaux derives de 3,3-dichloro-2-azetidinone, utiles notamment comme agents anti-inflammatoires | |
| ATE239699T1 (de) | Hydroxyphenylsulfanylbenzoesäure- und - arylessigsäure-derivate | |
| ES2051722T3 (es) | Procedimiento para estabilizar derivados de procaterol. | |
| ATE17481T1 (de) | 4-(substituiertes alkyl)-n-(1,3-dithiolan-2yliden)-anilin. | |
| IT1190662B (it) | Composto ad attivita' analgesica,antiinfiammatoria e mucoregolatrice procedimento per la sua prepatazione e relative composizioni farmaceutiche | |
| ATE20749T1 (de) | Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und solche enthaltende arzneimittel. |